Hrt Financial »

Outlook Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $341k 29k 11.91

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Merck & Co (MRK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Workday Cl A (WDAY)
CRH Ord (CRH)
General Motors Company (GM)
Automatic Data Processing (ADP)
Microsoft Corporation (MSFT)
Raytheon Technologies Corp (RTX)
Illinois Tool Works (ITW)
Johnson Ctls Intl SHS (JCI)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)

View all positions for Hrt Financial

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics